Pulmonx Corporation LUNG Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's additional paid-in capital?
- Pulmonx Corporation (LUNG) reported additional paid-in capital of $578.76M in Q1 2026.
- How has Pulmonx Corporation's additional paid-in capital changed year-over-year?
- Pulmonx Corporation's additional paid-in capital increased by 3.8% year-over-year, from $557.43M to $578.76M.
- What is the long-term trend for Pulmonx Corporation's additional paid-in capital?
- Over 5 years (2020 to 2025), Pulmonx Corporation's additional paid-in capital has grown at a 4.2% compound annual growth rate (CAGR), from $467.15M to $573.27M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.